State Street’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

State Street’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26,200	Closed	-$30K	–	5023
2022 Q2	$30K	Sell	26,200 -5	-0%	-$8	﹤0.01%	4822
2022 Q1	$134K	Buy	26,205 +1,135	+5%	+$7.14K	﹤0.01%	4535
2021 Q4	$141K	Hold	25,070	–	–	﹤0.01%	4485
2021 Q3	$278K	Buy	25,070 +493	+2%	+$6.2K	﹤0.01%	4231
2021 Q2	$417K	Sell	24,577 -53,427	-68%	-$1.01M	﹤0.01%	3927
2021 Q1	$2.05M	Buy	78,004 +935	+1%	+$42.5K	﹤0.01%	3428
2020 Q4	$2.79M	Buy	77,069 +13,638	+22%	+$493K	﹤0.01%	3232
2020 Q3	$2.25M	Buy	63,431 +13,371	+27%	+$581K	﹤0.01%	3151
2020 Q2	$2.13M	Buy	50,060 +31,951	+176%	+$2.15M	﹤0.01%	3158
2020 Q1	$1.45M	Sell	18,109 -565	-3%	-$45.2K	﹤0.01%	3195
2019 Q4	$1.73M	Buy	18,674 +4,654	+33%	+$393K	﹤0.01%	3291
2019 Q3	$1.06M	Buy	14,020 +1,414	+11%	+$109K	﹤0.01%	3383
2019 Q2	$1.26M	Buy	+12,606	New	+$976K	﹤0.01%	3377

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

State Street's EVFM Position: Q3 2022 in Review

State Street sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 26,200 shares — an estimated $30K sold.

State Street first reported a position in EVFM in Q2 2019 and held it in 13 quarters. The position peaked at $2.79M in Q4 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

State Street reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
State Street sold 26,200 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $30K.
State Street first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
State Street's Evofem Biosciences, Inc. Common Stock position peaked at $2.79M in Q4 2020.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.